MedTrace Logo

Endoscopic Sleeve Gastroplasty

NCT02948621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-01-08

No results posted yet for this study

Summary

The endoscopic sleeve gastroplasty allows stomach size reduction through an endoluminal suture approach without any incision. It could reduce the complications associated with current surgical techniques while obtaining the target gastric restriction, weight loss, comorbidities and quality of life improvement.

The primary objective of this study is to assess weight loss after endoscopic sleeve gastroplasty in patients with morbid obesity.

Conditions

  • Morbid Obesity

Interventions

PROCEDURE

Endoscopic sleeve gastroplasty

Endoscopic sleeve gastroplasty is performed using a CE marked endoscopic suture device (Overstitch, Apollo Endosurgery, Austin, Tx. USA). Continuous stitches are placed to create a sleeve-shaped gastric path of 2 cm diameter to reduce stomach volume from the proximal antrum to the oeso-gastric junction.

Sponsors & Collaborators

  • IHU Strasbourg

    lead OTHER

Principal Investigators

  • Silvana Perretta, MD, PhD · Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil de Strasbourg

  • Michel Vix, MD · Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil de Strasbourg

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-05-31
Completion
2020-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02948621 on ClinicalTrials.gov